The man who led Gilead’s au­toim­mune piv­ot heads to Boston; No­var­tis gets a new chief for its AI In­no­va­tion Cen­ter

The hos­pi­tal’s gone now but across the street from it, there used to be a clin­ic, a beat-up thing with peel­ing paint that, in a past life, a past city, had been a bank. John Sundy was a med­ical stu­dent train­ing at the hos­pi­tal, in down­town Philadel­phia. He walked in and saw a crowd of pa­tients in all man­ner of au­toim­mune con­di­tions wait­ing to see a tan, dis­tin­guished-look­ing man in a white lab coat: well-known rheuma­tol­o­gist Ralph De­Ho­r­atius.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.